These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 32779503

  • 41. Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease.
    Choubey PK, Tripathi A, Sharma P, Shrivastava SK.
    Bioorg Med Chem; 2020 Nov 15; 28(22):115721. PubMed ID: 33007563
    [Abstract] [Full Text] [Related]

  • 42. Design, synthesis and biological evaluation of new benzoxazolone/benzothiazolone derivatives as multi-target agents against Alzheimer's disease.
    Erdogan M, Kilic B, Sagkan RI, Aksakal F, Ercetin T, Gulcan HO, Dogruer DS.
    Eur J Med Chem; 2021 Feb 15; 212():113124. PubMed ID: 33395623
    [Abstract] [Full Text] [Related]

  • 43. Interest of novel N-alkylpyridinium-indolizine hybrids in the field of Alzheimer's disease: Synthesis, characterization and evaluation of antioxidant activity, cholinesterase inhibition, and amyloid fibrillation interference.
    Baussanne I, Firstova O, Dediu AB, Larosa C, Furdui B, Ghinea IO, Thomas A, Chierici S, Dinica R, Demeunynck M.
    Bioorg Chem; 2021 Nov 15; 116():105390. PubMed ID: 34670332
    [Abstract] [Full Text] [Related]

  • 44. Design, synthesis, evaluation and molecular modeling study of 4-N-phenylaminoquinolines for Alzheimer disease treatment.
    Zhu J, Wang LN, Cai R, Geng SQ, Dong YF, Liu YM.
    Bioorg Med Chem Lett; 2019 Jun 01; 29(11):1325-1329. PubMed ID: 30956012
    [Abstract] [Full Text] [Related]

  • 45. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
    Razavi SF, Khoobi M, Nadri H, Sakhteman A, Moradi A, Emami S, Foroumadi A, Shafiee A.
    Eur J Med Chem; 2013 Jun 01; 64():252-9. PubMed ID: 23644208
    [Abstract] [Full Text] [Related]

  • 46. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S, Bayraktar G, Tarikogullari AH, Alptüzün V, Erciyas E.
    Chem Pharm Bull (Tokyo); 2016 Jun 01; 64(9):1281-7. PubMed ID: 27581632
    [Abstract] [Full Text] [Related]

  • 47. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H, Jiang Y, Zhan J, Sun Y.
    Bioorg Chem; 2021 Sep 01; 114():105149. PubMed ID: 34252860
    [Abstract] [Full Text] [Related]

  • 48. Development of genistein-O-alkylamines derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z, Shi J, Zhou Y, Wang K, Zhao Y, Li Q, Qiao Z, Wu A, Tan Z, Liu W.
    Bioorg Chem; 2021 Feb 01; 107():104602. PubMed ID: 33453647
    [Abstract] [Full Text] [Related]

  • 49. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer's Activity Profile.
    Makhaeva GF, Kovaleva NV, Boltneva NP, Rudakova EV, Lushchekina SV, Astakhova TY, Serkov IV, Proshin AN, Radchenko EV, Palyulin VA, Korabecny J, Soukup O, Bachurin SO, Richardson RJ.
    Molecules; 2022 Feb 04; 27(3):. PubMed ID: 35164325
    [Abstract] [Full Text] [Related]

  • 50. Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Zhang Z, Guo J, Cheng M, Zhou W, Wan Y, Wang R, Fang Y, Jin Y, Liu J, Xie SS.
    Eur J Med Chem; 2021 Mar 05; 213():113154. PubMed ID: 33476932
    [Abstract] [Full Text] [Related]

  • 51. Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
    Wang D, Hu M, Li X, Zhang D, Chen C, Fu J, Shao S, Shi G, Zhou Y, Wu S, Zhang T.
    Eur J Med Chem; 2019 Apr 15; 168():207-220. PubMed ID: 30822710
    [Abstract] [Full Text] [Related]

  • 52. Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles.
    Samadi A, Marco-Contelles J, Soriano E, Alvarez-Pérez M, Chioua M, Romero A, González-Lafuente L, Gandía L, Roda JM, López MG, Villarroya M, García AG, Ríos Cde L.
    Bioorg Med Chem; 2010 Aug 15; 18(16):5861-72. PubMed ID: 20656495
    [Abstract] [Full Text] [Related]

  • 53. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.
    Mo J, Yang H, Chen T, Li Q, Lin H, Feng F, Liu W, Qu W, Guo Q, Chi H, Chen Y, Sun H.
    Bioorg Chem; 2019 Dec 15; 93():103310. PubMed ID: 31586704
    [Abstract] [Full Text] [Related]

  • 54. Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.
    Lan JS, Hou JW, Liu Y, Ding Y, Zhang Y, Li L, Zhang T.
    J Enzyme Inhib Med Chem; 2017 Dec 15; 32(1):776-788. PubMed ID: 28585866
    [Abstract] [Full Text] [Related]

  • 55. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates.
    Dias Viegas FP, de Freitas Silva M, Divino da Rocha M, Castelli MR, Riquiel MM, Machado RP, Vaz SM, Simões de Lima LM, Mancini KC, Marques de Oliveira PC, Morais ÉP, Gontijo VS, da Silva FMR, D'Alincourt da Fonseca Peçanha D, Castro NG, Neves GA, Giusti-Paiva A, Vilela FC, Orlandi L, Camps I, Veloso MP, Leomil Coelho LF, Ionta M, Ferreira-Silva GÁ, Pereira RM, Dardenne LE, Guedes IA, de Oliveira Carneiro Junior W, Quaglio Bellozi PM, Pinheiro de Oliveira AC, Ferreira FF, Pruccoli L, Tarozzi A, Viegas C.
    Eur J Med Chem; 2018 Mar 10; 147():48-65. PubMed ID: 29421570
    [Abstract] [Full Text] [Related]

  • 56. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
    Maqbool M, Manral A, Jameel E, Kumar J, Saini V, Shandilya A, Tiwari M, Hoda N, Jayaram B.
    Bioorg Med Chem; 2016 Jun 15; 24(12):2777-88. PubMed ID: 27157006
    [Abstract] [Full Text] [Related]

  • 57. New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    Luo XT, Wang CM, Liu Y, Huang ZG.
    Eur J Med Chem; 2015 Oct 20; 103():302-11. PubMed ID: 26363866
    [Abstract] [Full Text] [Related]

  • 58. Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease.
    Choubey PK, Tripathi A, Tripathi MK, Seth A, Shrivastava SK.
    Bioorg Chem; 2021 Jun 20; 111():104922. PubMed ID: 33945941
    [Abstract] [Full Text] [Related]

  • 59. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S, Ghobadian R, Mahdavi M, Nadri H, Moradi A, Akbarzadeh T, Najafi Z, Sharifzadeh M, Edraki N, Moghadam FH, Amini M.
    Daru; 2020 Dec 20; 28(2):463-477. PubMed ID: 32372339
    [Abstract] [Full Text] [Related]

  • 60. Design and synthesis of garlic-related unsymmetrical thiosulfonates as potential Alzheimer's disease therapeutics: In vitro and in silico study.
    Zilbeyaz K, Oztekin A, Kutluana EG.
    Bioorg Med Chem; 2021 Jun 15; 40():116194. PubMed ID: 33979775
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.